Technology | September 17, 2015

Siemens Announces FDA Clearance of Mammomat Fusion Mammography System

New full-field digital mammography system addresses specific needs of the midrange price segment, including small to medium-sized hospitals

Siemens, FDA clearance, Mammomat Fusion, mammography system

Mammomat Fusion image courtesy of Siemens Healthcare

September 17, 2015 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) recently cleared the Mammomat Fusion – the latest addition to the Siemens family of full-field digital mammography systems. The new system offers premium product features to address the specific needs of volume screening centers and small to medium-sized hospitals.

The Mammomat Fusion mammography system features a new-generation cesium-iodide detector – an innovative, layered configuration of the photo diodes within the detector that enables more efficient utilization of the radiation dose. The result: high image quality at a patient dose at or below the range of other full-field digital mammography systems; an even lower dose is delivered in cases where the patient’s breast thickness exceeds 50 mm. And the system’s large image matrix of 23 x 30 cm makes the Mammomat Fusion the right choice for screening various breast sizes.

In addition to the new detector, the system features selected technologies developed for Siemens’ premium Mammomat Inspiration platform. The OpDose feature ensures the radiation dose can be tailored for each patient without compromising image quality. The technologist can select the appropriate parameters in accordance with the patient’s breast size and density. The screening process is also simplified for clinical staff thanks to the compact, syngo-based Acquisition Workstation (AWS). Users can load patient data directly from the radiology information system without requiring a second workstation. Clinical personnel also benefit from an intuitive, automated workflow. The system is ready for scanning with just one click, with easy manual positioning.

In tomosynthesis mode, the Mammomat Inspiration X-ray tube rotates in a circular motion around the breast to acquire an image every two degrees while moving through an angular range of 50 degrees; the resulting 25 projections are reconstructed as 3-D digital breast tomosynthesis images.

For more information: www.usa.siemens.com/healthcare

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init